+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Quantitative comparisons of pharmacokinetic drug interactions: a probabilistic approach

Quantitative comparisons of pharmacokinetic drug interactions: a probabilistic approach

Methods and Findings in Experimental and Clinical Pharmacology 10(11): 711-716

An empirically-based approach which permits the comparison of changes in plasma clearance caused by pharmacokinetic drug-interactions is described. The analysis is based on the calculation of simple probability ratios for defined ranges of clearance changes that are caused by one of the interacting drugs. Examples of drugs increasing the clearance of a second drug through enzyme induction and of drugs decreasing the clearance of a second drug through enzyme inhibition are given. Data for each pair of interacting drugs is empirically fitted using either exponential or logarithmic functions. For each type of interaction a family of curves is generated which permits quantitative comparisons of both the extent and frequency of changes in plasma clearance caused by the interaction.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 007714154

Download citation: RISBibTeXText

PMID: 3221744

Related references

Evaluation of pharmacokinetic drug-drug-interactions. Critical considerations of the relevance of pharmacokinetic drug-drug interactions of proton pump inhibitors in self medication. Medizinische Monatsschrift für Pharmazeuten 34(8): 270-278, 2011

Quantitative Prediction of Drug-Drug Interactions Involving Inhibitory Metabolites in Drug Development: How Can Physiologically Based Pharmacokinetic Modeling Help?. Cpt: Pharmacometrics and Systems Pharmacology 5(10): 505-515, 2016

Drug-metabolism mechanism: Knowledge-based population pharmacokinetic approach for characterizing clobazam drug-drug interactions. Journal of Clinical Pharmacology 56(3): 365-374, 2016

Bioavailability considerations in evaluating drug-drug interactions using the population pharmacokinetic approach. Journal of Clinical Pharmacology 51(7): 1087-1100, 2011

Quantitative analysis of pharmacokinetic profiles of verapamil and drug-drug interactions induced by a CYP inhibitor using a stable isotope-labeled compound. Drug Metabolism and Pharmacokinetics 31(6): 405-410, 2016

Predicting drug-drug interactions: application of physiologically based pharmacokinetic models under a systems biology approach. Expert Review of Clinical Pharmacology 6(2): 143-157, 2013

A physiologically based pharmacokinetic modeling approach to predict drug-drug interactions between domperidone and inhibitors of CYP3A4. Biopharmaceutics and Drug Disposition 37(1): 15-27, 2016

Prediction of drug-drug interactions between various antidepressants and efavirenz or boosted protease inhibitors using a physiologically based pharmacokinetic modelling approach. Clinical Pharmacokinetics 52(7): 583-592, 2013

Utilizing In Vitro Dissolution-Permeation Chamber for the Quantitative Prediction of pH-Dependent Drug-Drug Interactions with Acid-Reducing Agents: a Comparison with Physiologically Based Pharmacokinetic Modeling. Aaps Journal 18(6): 1512-1523, 2016

Use of a Physiologically Based Pharmacokinetic Model for Quantitative Prediction of Drug-Drug Interactions via CYP3A4 and Estimation of the Intestinal Availability of CYP3A4 Substrates. Journal of Pharmaceutical Sciences 104(9): 3183-3193, 2015

Analysis of drug-receptor interactions in vivo: a new approach in pharmacokinetic-pharmacodynamic modelling. International Journal of Clinical Pharmacology and Therapeutics 35(10): 442-446, 1997

Exploration of the African green monkey as a preclinical pharmacokinetic model: oral pharmacokinetic parameters and drug-drug interactions. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 39(3): 266-272, 2009

Prediction of pharmacokinetic drug/drug interactions from In vitro data: interactions of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants. Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(2): 161-168, 2000

A Physiologically Based Pharmacokinetic Modeling Approach to Predict Diseasea Drug Interactions Suppression of CYP3A by IL-6. 2013

Virtual Clinical Trial Toward Polytherapy Safety Assessment: Combination of Physiologically Based Pharmacokinetic/Pharmacodynamic-Based Modeling and Simulation Approach With Drug-Drug Interactions Involving Terfenadine as an Example. Journal of Pharmaceutical Sciences 105(11): 3415-3424, 2016